MOG and myeloid sarcoma: This model is consistent with the induction method of MS, specifically combining myelin oligodendrocyte glycoprotein residues 35–55 (MOG35−55) with immunostimulant to induce the generation of pathogenic Th1 and Th17 cells (4).